http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-111014-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8b0758a8fee40500135d3d128734b21 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate | 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cd280154dcd7550852e7a3a1c2dc8e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97ad9924cc8dee70d620fdf87beb8350 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c936aed4ce7be1618ed89e50e0f8a8fb |
| publicationDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-111014-C2 |
| titleOfInvention | A METHOD OF TREATMENT OF GENERALIZED ANXIETY DISORDERS OF ONCOLOGICAL PATIENTS WHO SURGED SURGICAL INTERVENTION WITH THE FORMATION OF THE INTENTION |
| abstract | The invention relates to medicine, namely psychiatry, and can be used for monotherapy of generalized anxiety disorders in cancer patients. A method of treating generalized anxiety disorders in cancer patients who underwent surgery with the formation of an intestinal stoma, is to administer to patients orally Atarax (Hydroxizine) at a dose of 50 mg (2 tablets) in three doses (12.5 mg in the morning, afternoon and 25 mg in the evening) for three months against the background of cognitive-behavioral psychotherapy using new, socially acceptable behavioral patterns. |
| priorityDate | 2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.